Growth Metrics

Quest Diagnostics (DGX) Operating Income: 2009-2025

Historic Operating Income for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $386.0 million.

  • Quest Diagnostics' Operating Income rose 16.97% to $386.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 22.28%. This contributed to the annual value of $1.3 billion for FY2024, which is 6.66% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Operating Income is $386.0 million, which was down 11.87% from $438.0 million recorded in Q2 2025.
  • Quest Diagnostics' Operating Income's 5-year high stood at $660.0 million during Q1 2021, with a 5-year trough of $135.0 million in Q4 2022.
  • Over the past 3 years, Quest Diagnostics' median Operating Income value was $346.0 million (recorded in 2025), while the average stood at $343.5 million.
  • Its Operating Income has fluctuated over the past 5 years, first soared by 277.14% in 2021, then plummeted by 74.81% in 2022.
  • Quarterly analysis of 5 years shows Quest Diagnostics' Operating Income stood at $536.0 million in 2021, then tumbled by 74.81% to $135.0 million in 2022, then soared by 97.78% to $267.0 million in 2023, then soared by 35.21% to $361.0 million in 2024, then rose by 16.97% to $386.0 million in 2025.
  • Its Operating Income stands at $386.0 million for Q3 2025, versus $438.0 million for Q2 2025 and $346.0 million for Q1 2025.